Closing the Daily Disposable Gap in Presbyopic Astigmatism - Scorecard - MDSpire

Closing the Daily Disposable Gap in Presbyopic Astigmatism

New multifocal toric daily disposable lens highlights a broader shift in how the profession is approaching one of its most complex – and common – patient groups

  • February 17, 2026

  • 3 min

Share

Clinical Scorecard: Closing the Daily Disposable Gap in Presbyopic Astigmatism

At a Glance

CategoryDetail
ConditionPresbyopic Astigmatism
Key MechanismsCombination of toric and multifocal correction in contact lenses.
Target PopulationPatients with both astigmatism and presbyopia.
Care SettingOptometry practices in the UK and Ireland.

Key Highlights

  • First daily disposable multifocal toric lens launched in the UK and Ireland.
  • 91% first-fit success rate reported at initial visit.
  • Addresses high dropout rates among contact lens wearers.
  • Includes updated fitting tools for clinicians.
  • Launch effective from February 2026.

Guideline-Based Recommendations

Diagnosis

  • Assess for both astigmatism and presbyopia in patients.

Management

  • Utilize ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM for appropriate patients.

Monitoring & Follow-up

  • Evaluate patient satisfaction and lens performance during follow-up visits.

Risks

  • Monitor for potential dropout due to dissatisfaction with vision quality and comfort.

Patient & Prescribing Data

Individuals experiencing both astigmatism and presbyopia.

The new lens aims to improve comfort and visual performance across multiple distances.

Clinical Best Practices

  • Use digital fitting calculators to enhance fitting accuracy.
  • Incorporate demonstration devices to explain lens benefits to patients.

References

Original Source(s)

Closing the Daily Disposable Gap in Presbyopic Astigmatism

  • February 17, 2026

Related Content

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Shape-Changing IOL Shows Durability

Atia Vision reports positive 36-month data for its shape-changing IOL at ASCRS 2026

  • April 28, 2026

  • 3 min
AI in Practice: AI as a Second Opinion